bpc-157 clinical trial human randomized controlled trial Pentadecapeptide BPC 157 (capitals) prevented muscle atrophy and What Is BPC-157? A Medical
Description
Biochemical and clinical response to hydroxocobalamin versus cyanocobalamin treatment in patients with methylmalonic acidemia and homocystinuria (cblC) 1998
Spine 23 , 24932506 (1998)
These treatments are not first-line options
Dont co-lyophilise or co-store reconstituted solutions of the two peptides unless stability of the combination has been specifically validated
